Finnadvance Oy develops disease-on-chip for drug discovery and for research. The chips mimic functions of a human organ and allow for more precise and expedient drug discovery. This lowers costs by reducing the need for animal studies. The chips are used to find potential drug candidates for rare diseases and to study efficacy and response. This work will eventually lead to the development of real personalized medicines.

The Intervention Radiology Systems (IRS) – the Skolkovo participant, the developer of the stereotaxic holder of a medical product for carrying out low-invasive operations under CT/MRI monitoring . At the moment there is a working prototype of a product which passes clinical tests within scientific work in the Voronezh regional clinical hospital (500 operations a year)

ASPM - is a Innovative Company, the leader in the R&D, production and application of thin coatings, which are used to produce multifunctional (anti-ice, anti-corrosion, anti-adhesive, anti-friction, hydrophobic, bactericidal, disinfectant) nanosized films with a thickness from 10-100 nm.

The company has the “Russian Nanoproducts” mark, the certificate of “NanoCertificate”, ISO, “RSt” and also holds patents of the European, EAPO, PCT applications registered with the Trademark Certificates in the RF, EU, WIPO system, is a regular participant international and regional industrial exhibitions, scientific conferences and seminars.

Framebiotek LLC was founded in 2020 in St-Petersburg, Russia. Framebiotek has a full-cycle platform for the development of innovative and generic / biosimilar products and technologies: from idea and molecule design through the technology scaling up and transfer to the local approval. Framebiotek platform are based on the own capacities and competencies of employees as well as friendly laboratories and centers, which are united together by the universal framework used common tools and values. Framebiotek team members have at least 10-years experience to get a success in product and technology development and most of them have PhD degree in biology, chemistry, technology, project management, etc.

PanDх is a startup from Saint-Petersburg. Our company develops novel medical device - catheter “IsyCath”. It addresses unmet medical needs in treating and diagnosing serious and life-threatening conditions of GI and hepato-biliary systems. It is designed to create an isolated area and a controlled environment in an isolated area of gastrointestinal (GI) tract. At the same time, it maintains the connectivity and function of GI tract.